Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 83
Filtrar
1.
J Med Case Rep ; 18(1): 272, 2024 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-38849848

RESUMO

BACKGROUND: To report a case of Multiple Evanescent White Dot Syndrome (MEWDS) one month after a COVID-19 infection in a female patient at an age unusual for the occurrence of this disease. CASE PRESENTATION: A 69-year-old Caucasian female reported the presence of floaters, photopsia, and enlarging vision loss in her left eye following the COVID-19 infection. Clinical and multimodal imaging was consistent with the MEWDS diagnosis. Fluorescein angiography examination revealed characteristic hyperfluorescent spots around the fovea in a wreath-like pattern. An extensive lab workup to rule out other autoimmune and infectious etiologies was inconclusive. Visual acuity and white dots resolved after a course of corticosteroids, which was confirmed on follow-up dilated fundus exam and multimodal imaging. CONCLUSIONS: MEWDS is a rare white dot syndrome that may occur following COVID-19 infection in addition to other reported ophthalmic disorders following this infection.


Assuntos
COVID-19 , Angiofluoresceinografia , Humanos , Feminino , COVID-19/complicações , Idoso , SARS-CoV-2 , Tomografia de Coerência Óptica , Síndrome dos Pontos Brancos , Acuidade Visual , Doenças Retinianas/virologia , Doenças Retinianas/etiologia , Transtornos da Visão/etiologia , Transtornos da Visão/virologia
2.
Am J Trop Med Hyg ; 110(6): 1172-1177, 2024 Jun 05.
Artigo em Inglês | MEDLINE | ID: mdl-38697090

RESUMO

The incidence and geographic distribution of dengue has increased dramatically in recent years across various parts of the world. Previously, ocular findings in dengue fever were considered rare. We report a spectrum of ocular manifestations presenting with vision loss in the last dengue epidemic in an eastern state of India. This is a retrospective interventional case series of patients with vision loss who were diagnosed with dengue eye disease in the 2022 epidemic. Systemic and ophthalmic examinations were completed on all patients and were analyzed. Fifteen patients had presented with vision loss. The mean age was 41.7 ± 10.8 years, and patients were mostly males. Three patients presented with panophthalmitis and orbital cellulitis. Eight patients were diagnosed with optic neuropathy. Four patients had macular involvement: macular chorioretinitis, macular subhyaloid hemorrhage, and macular hemorrhages in two patients. All patients with optic neuropathy gave a history of mild fever and had remained undiagnosed. The rest had been diagnosed with the more severe dengue hemorrhagic fever. Vision recovered partially or fully in patients with optic neuropathy and macular disease. No eye could be salvaged in any panophthalmitis patients. Thrombocytopenia (platelet count <100 × 109 per liter of blood) was significantly associated with ocular hemorrhage and panophthalmitis, but thrombocytopenia was not significantly seen in optic neuropathy. We conclude that optic neuropathy may be an underreported cause of vision loss in dengue fever. An eye examination is advocated in all patients with dengue eye disease.


Assuntos
Dengue , Humanos , Masculino , Índia/epidemiologia , Adulto , Feminino , Pessoa de Meia-Idade , Estudos Retrospectivos , Dengue/complicações , Dengue/epidemiologia , Transtornos da Visão/etiologia , Transtornos da Visão/virologia , Transtornos da Visão/epidemiologia , Doenças do Nervo Óptico/epidemiologia , Doenças do Nervo Óptico/etiologia , Panoftalmite/epidemiologia , Trombocitopenia/epidemiologia
5.
Restor Neurol Neurosci ; 39(6): 393-408, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34924406

RESUMO

BACKGROUND: An effective treatment is needed for long-COVID patients which suffer from symptoms of vision and/or cognition impairment such as impaired attention, memory, language comprehension, or fatigue. OBJECTIVE: Because COVID-19infection causes reduced blood flow which may cause neuronal inactivation, we explored if neuromodulation with non-invasive brain stimulation using microcurrent (NIBS), known to enhance blood flow and neuronal synchronization, can reduce these symptoms. METHODS: Two female long-COVID patients were treated for 10-13 days with alternating current stimulation of the eyes and brain. While one patient (age 40) was infected with the SARS CoV-2 virus, the other (age 72) developed symptoms following AstraZeneca vaccination. Before and after therapy, cognition was assessed subjectively by interview and visual fields quantified using perimetry. One patient was also tested with a cognitive test battery and with a retinal dynamic vascular analyser (DVA), a surrogate marker of vascular dysregulation in the brain. RESULTS: In both patients NIBS markedly improved cognition and partially reversed visual field loss within 3-4 days. Cognitive tests in one patient confirmed recovery of up to 40-60% in cognitive subfunctions with perimetry results showing stable and visual field recovery even during follow-up. DVA showed that NIBS reduced vascular dysregulation by normalizing vessel dynamics (dilation/constriction), with particularly noticeable changes in the peripheral veins and arteries. CONCLUSIONS: NIBS was effective in improving visual and cognitive deficits in two confirmed SARS-COV-2 patients. Because recovery of function was associated with restoration of vascular autoregulation, we propose that (i) hypometabolic, "silent" neurons are the likely biological cause of long-COVID associated visual and cognitive deficits, and (ii) reoxygenation of these "silent" neurons provides the basis for neural reactivation and neurological recovery. Controlled trials are now needed to confirm these observations.


Assuntos
COVID-19 , Disfunção Cognitiva , Terapia por Estimulação Elétrica , Transtornos da Visão , Adulto , Idoso , Encéfalo , COVID-19/complicações , Disfunção Cognitiva/terapia , Disfunção Cognitiva/virologia , Feminino , Humanos , Transtornos da Visão/terapia , Transtornos da Visão/virologia , Síndrome de COVID-19 Pós-Aguda
6.
J Rheumatol ; 48(7): 1053-1059, 2021 07.
Artigo em Inglês | MEDLINE | ID: mdl-33060304

RESUMO

OBJECTIVE: To identify shared and distinct features of giant cell arteritis (GCA) and coronavirus disease 2019(COVID-19) to reduce diagnostic errors that could cause delays in correct treatment. METHODS: Two systematic literature reviews determined the frequency of clinical features of GCA and COVID-19 in published reports. Frequencies in each disease were summarized using medians and ranges. RESULTS: Headache was common in GCA but was also observed in COVID-19 (GCA 66%, COVID-19 10%). Jaw claudication or visual loss (43% and 26% in GCA, respectively) generally were not reported in COVID-19. Both diseases featured fatigue (GCA 38%, COVID-19 43%) and elevated inflammatory markers (C-reactive protein [CRP] elevated in 100% of GCA, 66% of COVID-19), but platelet count was elevated in 47% of GCA but only 4% of COVID-19 cases. Cough and fever were commonly reported in COVID-19 and less frequently in GCA (cough, 63% for COVID-19 vs 12% for GCA; fever, 83% for COVID-19 vs 27% for GCA). Gastrointestinal upset was occasionally reported in COVID-19 (8%), rarely in GCA (4%). Lymphopenia was more common in COVID-19 than GCA (53% in COVID-19, 2% in GCA). Alteration of smell and taste have been described in GCA but their frequency is unclear. CONCLUSION: Overlapping features of GCA and COVID-19 include headache, fever, elevated CRP and cough. Jaw claudication, visual loss, platelet count and lymphocyte count may be more discriminatory. Physicians should be aware of the possibility of diagnostic confusion. We have designed a simple checklist to aid evidence-based evaluation of patients with suspected GCA.


Assuntos
COVID-19 , Arterite de Células Gigantes , COVID-19/diagnóstico , Diagnóstico Diferencial , Arterite de Células Gigantes/diagnóstico , Cefaleia/diagnóstico , Cefaleia/etiologia , Humanos , Transtornos da Visão/diagnóstico , Transtornos da Visão/virologia
7.
BMJ Case Rep ; 13(12)2020 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-33318255

RESUMO

Influenza-associated encephalopathy/encephalitis (IAE) can result in serious neurological complications. We report a 4-year-old healthy female child with the diagnosis of IAE. Her clinical course was complicated by temporary visual impairment and significant motor deficits. Her unique ophthalmological findings have little precedent in previous literature.


Assuntos
Encefalopatias/diagnóstico , Encefalopatias/virologia , Influenza Humana/complicações , Transtornos da Visão/diagnóstico , Transtornos da Visão/virologia , Encéfalo/patologia , Encéfalo/virologia , Encefalopatias/fisiopatologia , Pré-Escolar , Feminino , Humanos , Vírus da Influenza B , Imageamento por Ressonância Magnética , Transtornos da Visão/fisiopatologia
9.
Afr Health Sci ; 20(2): 656-657, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33163027

RESUMO

BACKGROUND: The objectives of the article are to assess the role of a strategic response in the prevention and control of the disease and the need for extending supports to the survivors of disease. INTRODUCTION: Since the start of the August last year, a new outbreak of Ebola virus disease has been reported in provinces of the Democratic Republic of the Congo. METHODS: As of now, close to 1170 cases and 740 deaths have been attributed to the diseases due to the associated complications in the region.As of now, close to 1170 cases and 740 deaths have been attributed to the diseases due to the associated complications in the region. RESULT: In order to effectively respond to the outbreak, a wide range of strategies have been proposed. It is a fact that the survivors of the disease outbreak face multiple challenges, the task of organizing eye clinics to promote early detection of the problems among the survivors has been initiated. CONCLUSION: In conclusion, Ebola virus disease is a life threatening disease and is linked with a wide range of complications, including those involving eyes. Thus, the need of the hour is to formulate a strategic response comprising of different strategies which not only aim to reduce the incidence of the disease, but also to extend quality assured care to the survivors.


Assuntos
Surtos de Doenças/prevenção & controle , Oftalmopatias/etiologia , Doença pelo Vírus Ebola/complicações , Uveíte/virologia , Transtornos da Visão/virologia , República Democrática do Congo/epidemiologia , Programas de Triagem Diagnóstica , Serviços de Saúde , Doença pelo Vírus Ebola/epidemiologia , Humanos , Sobreviventes , Uveíte/diagnóstico , Transtornos da Visão/diagnóstico
11.
J Korean Med Sci ; 35(35): e322, 2020 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-32893523

RESUMO

BACKGROUND: The coronavirus disease 2019 (COVID-19) has reportedly affected almost 23 million people, with more than 800 thousand deaths globally. There have been a few reports on the ocular manifestations of COVID-19 patients in China but no reports in Korea. The present study aimed to examine ocular manifestations of COVID-19 patients in Korea. METHODS: COVID-19 patients admitted from March 2020 to April 2020 at Keimyung University Dongsan Hospital and Keimyung University Daegu Dongsan Hospital were reviewed retrospectively for ocular manifestations. During the period of hospitalization, ocular symptoms as well as blood test results were noted and analyzed. Patients were then divided into the first-episode and relapsed group and ocular symptoms were analyzed in the groups. RESULTS: A total of 103 patients were included in this study. Among them, 71patients were in the first-episode group and 32 patients in the relapsed group. No significant differences were determined in terms of positivity of ocular symptoms between the first-episode group (12 patients, 16.9%) and the relapsed group (10 patients, 31.3%, P > 0.05). Symptoms of positive upper respiratory infection and lower creatine phosphokinase were determined to be related to positive ocular symptoms. Conjunctival congestion was noted in seven patients. In the subgroup analysis, the conjunctival congestion-positive patients exhibited higher positivity of upper respiratory infection symptoms (100%) as compared with those in the negative group (40%, P = 0.017). CONCLUSION: Positive upper respiratory infection symptoms and lower creatine phosphokinase were determined to be related to ocular symptoms in COVID-19 patients. Among these patients, positive upper respiratory infection symptoms were associated with conjunctival congestion.


Assuntos
Doenças da Túnica Conjuntiva/patologia , Infecções por Coronavirus/patologia , Creatina Quinase/sangue , Pneumonia Viral/patologia , Transtornos da Visão/patologia , Adulto , Betacoronavirus/patogenicidade , Proteína C-Reativa/análise , COVID-19 , Doenças da Túnica Conjuntiva/virologia , Síndromes do Olho Seco/patologia , Síndromes do Olho Seco/virologia , Feminino , Humanos , L-Lactato Desidrogenase/sangue , Masculino , Pessoa de Meia-Idade , Pandemias , Pró-Calcitonina/sangue , República da Coreia , Estudos Retrospectivos , SARS-CoV-2 , Transtornos da Visão/virologia
12.
Ocul Immunol Inflamm ; 28(7): 1085-1093, 2020 Oct 02.
Artigo em Inglês | MEDLINE | ID: mdl-31961200

RESUMO

Purpose: To review the broad spectrum of clinical neuro-ophthalmic presentations associated with human immunodeficiency virus (HIV) infection. Methods: Critical review of the literature regarding neuro-ophthalmic consequences of HIV infection and its sequelae. Results: Neuro-ophthalmological diseases are common in both asymptomatic HIV-positive patients and those who profound immunosuppression with acquired immune deficiency syndrome (AIDS). Neuro-ophthalmic manifestations of HIV infection can involve the afferent or efferent visual pathway. Common clinical presentations include headache, papilledema, chorioretinitis, optic nerve involvement, meningitis, and cranial nerve palsies. Other neuro-ophthalmic manifestations include involvement of the visual pathway in the brain producing visual field defects such as occur in progressive multifocal encephalopathy. Pupil abnormalities have also been reported. Discussion: Neuro-ophthalmic consequences of HIV are important to recognize as it is critical to identify underlying neoplastic or infectious diseases which could be amenable to treatment.


Assuntos
Coriorretinite/diagnóstico , Infecções Oculares Virais/diagnóstico , Infecções por HIV/diagnóstico , Doenças do Nervo Óptico/diagnóstico , Papiledema/diagnóstico , Coriorretinite/virologia , Infecções Oculares Virais/virologia , Infecções por HIV/virologia , Humanos , Doenças do Nervo Óptico/virologia , Papiledema/virologia , Transtornos da Visão/diagnóstico , Transtornos da Visão/virologia , Campos Visuais
14.
Curr Opin Ophthalmol ; 30(6): 500-505, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31503074

RESUMO

PURPOSE OF REVIEW: There are an increasing number of publications related to dengue ophthalmic manifestations and multimodality imaging related to dengue. This review summarizes the current literature, describe ocular manifestations, current using of ocular imaging/investigations, and management of ocular dengue. RECENT FINDINGS: Ocular manifestations of dengue can be present in many stages of dengue fever including after the resolution of systemic disease. Most cases of ocular dengue will exhibit an improvement in vision spontaneously over time. Multimodal imaging such as optical coherence tomography, optical coherence tomography angiography, near-infrared imaging, and microperimetry plays an important role in the diagnosis, follow-up, quantitative measure, and help to understand the disease progression. SUMMARY: Dengue fever can lead to a variety of ocular manifestations. The mechanisms underlying dengue-related ocular complications remain unclear. Immune-mediated mechanisms and direct viral invasion are thought to play an important role. Ophthalmologists should carefully assess patients with dengue-related ophthalmic disease because some patients may have poor visual acuity and exhibit refractoriness to treatment. Treatment with systemic corticosteroids may benefit those patients with poor presenting visual acuity, progressive ocular symptoms, and lesions involving the optic nerve and/or threatening the macula.


Assuntos
Dengue/diagnóstico , Infecções Oculares Virais/diagnóstico , Transtornos da Visão/diagnóstico , Dengue/virologia , Infecções Oculares Virais/virologia , Angiofluoresceinografia , Humanos , Imagem Multimodal , Espectrofotometria Infravermelho , Tomografia de Coerência Óptica/métodos , Transtornos da Visão/virologia , Testes de Campo Visual
15.
Int J Rheum Dis ; 22(7): 1331-1334, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31117158

RESUMO

We present a case of an elderly, immunosuppressed patient with rheumatoid arthritis who was not appropriately vaccinated, and subsequently developed herpes zoster ophthalmicus, which initially presented similar to giant cell arteritis. Evidence-based vaccinations are integral in decreasing the incidence of preventable diseases and promoting optimal health at the individual and population level. Although the patient ultimately did not suffer any long-term adverse sequelae, this case highlights the importance of vaccination in the rheumatology setting, and to consider both inflammatory and infectious causes of headache and vision changes in the elderly.


Assuntos
Antirreumáticos/efeitos adversos , Artrite Reumatoide/tratamento farmacológico , Cefaleia/virologia , Herpes Zoster Oftálmico/virologia , Herpesvirus Humano 3/patogenicidade , Infecções Oportunistas/virologia , Transtornos da Visão/virologia , Idoso de 80 Anos ou mais , Antivirais/uso terapêutico , Artrite Reumatoide/diagnóstico , Artrite Reumatoide/imunologia , Cefaleia/diagnóstico , Cefaleia/tratamento farmacológico , Cefaleia/imunologia , Herpes Zoster Oftálmico/diagnóstico , Herpes Zoster Oftálmico/tratamento farmacológico , Herpes Zoster Oftálmico/imunologia , Herpesvirus Humano 3/efeitos dos fármacos , Herpesvirus Humano 3/imunologia , Humanos , Hospedeiro Imunocomprometido , Masculino , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/tratamento farmacológico , Infecções Oportunistas/imunologia , Resultado do Tratamento , Transtornos da Visão/diagnóstico , Transtornos da Visão/tratamento farmacológico , Transtornos da Visão/imunologia
16.
Pediatr Nephrol ; 34(7): 1247-1252, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30874941

RESUMO

BACKGROUND: Hantavirus infections are endemic worldwide, and its incidence in Europe has been steadily increasing. In Western Europe, hantavirus infections are typically caused by Puumala hantavirus and cause nephropathia epidemica (NE), a mild form of haemorrhagic fever with renal syndrome. Up to now, there is only little data about the course of acute NE in children, but it has been suggested that hantavirus infections take a lighter course in children when compared to adults. We performed a retrospective analysis of adults and children diagnosed with acute NE in two counties in South-Western Germany to investigate if there are differences in the course of the disease. METHODS: We reviewed the medical records of 295 adults and 22 children with acute NE regarding clinical presentation, laboratory findings, complications and outcome. RESULTS: Acute kidney injury (AKI) and thrombocytopenia occurred at similar frequencies and severity in both groups. Sudden onset of fever and back/loin pain were two of the three most common symptoms in both adults and children. However, adults presented more frequently with arthralgia and visual disturbances, whereas abdominal pain and nausea/vomiting could be detected more often in children. No significant differences were found in the incidence of complications (haemodialysis, long-term outcome of kidney function, length of hospital stay). CONCLUSIONS: The clinical course of acute NE was similar in adults and children with high frequency of AKI as well as thrombocytopenia, but with full recovery of all patients.


Assuntos
Injúria Renal Aguda/virologia , Febre Hemorrágica com Síndrome Renal/complicações , Virus Puumala , Trombocitopenia/virologia , Dor Abdominal/virologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Artralgia/virologia , Dor nas Costas/virologia , Criança , Feminino , Febre/virologia , Febre Hemorrágica com Síndrome Renal/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Náusea/virologia , Estudos Retrospectivos , Transtornos da Visão/virologia , Vômito/virologia , Adulto Jovem
17.
PLoS Negl Trop Dis ; 13(3): e0007209, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30845141

RESUMO

BACKGROUND: In the wake of the West African Ebola virus disease (EVD) outbreak of 2014-2016, thousands of EVD survivors began to manifest a constellation of systemic and ophthalmic sequelae. Besides systemic arthralgias, myalgias, and abdominal pain, patients were developing uveitis, a spectrum of inflammatory eye disease leading to eye pain, redness, and vision loss. To investigate this emerging eye disease, resources and equipment were needed to promptly evaluate this sight-threatening condition, particularly given our identification of Ebola virus in the ocular fluid of an EVD survivor during disease convalescence. METHODOLOGY/PRINCIPAL FINDINGS: A collaborative effort involving ophthalmologists, infectious disease specialists, eye care nurses, and physician leadership at Eternal Love Winning Africa (ELWA) Hospital in Liberia led to the development of a unique screening eye clinic for EVD survivors to screen, treat, and refer patients for more definitive care. Medications, resources, and equipment were procured from a variety of sources including discount websites, donations, purchasing with humanitarian discounts, and limited retail to develop a screening eye clinic and rapidly perform detailed ophthalmologic exams. Findings were documented in 96 EVD survivors to inform public health officials and eye care providers of the emerging disease process. Personal protective equipment was tailored to the environment and implications of EBOV persistence within intraocular fluid. CONCLUSIONS/SIGNIFICANCE: A screening eye clinic was feasible and effective for the rapid screening, care, and referral of EVD survivors with uveitis and retinal disease. Patients were screened promptly for an initial assessment of the disease process, which has informed other efforts within West Africa related to immediate patient care needs and our collective understanding of EVD sequelae. Further attention is needed to understand the pathogensis and treatment of ophthalmic sequelae given recent EVD outbreaks in West Africa and ongoing outbreak within Democratic Republic of Congo.


Assuntos
Instituições de Assistência Ambulatorial , Programas de Triagem Diagnóstica , Implementação de Plano de Saúde , Doença pelo Vírus Ebola/complicações , Transtornos da Visão/diagnóstico , Transtornos da Visão/virologia , Programas de Triagem Diagnóstica/economia , Programas de Triagem Diagnóstica/estatística & dados numéricos , Surtos de Doenças , Ebolavirus/patogenicidade , Economia Hospitalar , Equipamentos e Provisões Hospitalares/economia , Olho/virologia , Recursos em Saúde , Hospitais , Humanos , Libéria , Sobreviventes , Uveíte/diagnóstico , Uveíte/etiologia
18.
Retin Cases Brief Rep ; 13(2): 171-173, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-28221261

RESUMO

PURPOSE: To report a case of unilateral maculopathy associated with acute Zika virus infection. METHODS: Observational case report of one patient. RESULTS: A 22-year-old man presented with acute blurring of vision 10 days after symptoms of Zika virus infection. Findings resembling unilateral acute idiopathic maculopathy of the right eye were noted on ophthalmoscopy, fluorescein angiography, indocyanine green angiography, and optical coherence tomography. Localized macular dysfunction in the right eye was noted on multifocal electroretinography. The left eye was normal. He was managed conservatively with resolution of symptoms in 3 weeks. CONCLUSION: We describe a case of unilateral acute idiopathic maculopathy-like disease in a patient with reverse transcriptase polymerase chain reaction-confirmed Zika virus infection.


Assuntos
Infecções Oculares Virais/virologia , Doenças Retinianas/virologia , Transtornos da Visão/virologia , Infecção por Zika virus/diagnóstico , Humanos , Masculino , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA